Flagship Ventures
Flagship Pioneering, Quotient Therapeutics Team up for Pfizer Drug Discovery Partnership
Under the agreement, the companies aim to discover new drug targets in cardiovascular and renal diseases using Quotient's cell phenotyping and genomic sequencing platform.
Codiak BioSciences Launches With $80M Financing to Develop Exosome-Based Products
The new firm will be based in the Boston area and is co-founded by MD Anderson Professor Raghu Kalluri and Broad Institute Director Eric Lander.
Movers & Shakers: Jul 29, 2011
Premium
Glenn Barney, Dario Alessi, Philip Cohen, Stephane Bancel, Noubar Afeyan
Silicon Valley remained the top US cluster with $210 million in first-quarter venture capital, down a little over 16 percent from the $251 million racked up a year earlier. New England's $149 million in biopharma VC marked a nearly 32 percent fall-off.
Apr 10, 2009
Helicos Updates Filing for Selling Shareholders
Feb 17, 2009
Short Reads: Feb 17, 2009
Premium
Feb 2, 2009